Comparison of Right and Left Ventricular Responses to Left Ventricular Assist Device Support in Patients With Severe Heart Failure
- 7 August 2001
- journal article
- other
- Published by Wolters Kluwer Health in Circulation
- Vol. 104 (6) , 670-675
Abstract
Background — Left ventricular assist devices (LVAD) reverse ventricular, myocardial, and systemic abnormalities characteristic of severe heart failure (reverse remodeling). The relative contributions of hemodynamic unloading and normalized biochemical milieu to reverse remodeling are unknown. Methods and Results — Structural and functional characteristics were measured from 53 hearts of patients undergoing transplantation without LVAD support (medical support) and 33 hearts from patients receiving a median of 46 days of LVAD support (range, 8 to 360 days). Compared with medical support alone, patients receiving LVAD support for ≥30 days had higher central venous pressures (11±6 versus 8±5 mm Hg, P =0.04), lower pulmonary artery diastolic pressures (14±9 versus 21±9 mm Hg, P =0.01), and higher cardiac outputs (5.1±1.6 versus 3.7±1.0 L/min, P 30 (ex vivo volume yielding ventricular pressure of 30 mm Hg) was decreased in the left ventricle (LV) (179±75 versus 261±118 mL, P =0.005) but not in the right ventricle (RV) (140±59 versus 148±52 mL, P =NS). LV myocyte diameter decreased more significantly after LVAD support (17%, P =0.05) than in the RV (11%, P =NS). Compared with transplantation, LVAD support increased normalized SERCA2a content in the LV (0.51±0.26 versus 1.04±0.34, P P =NS). Finally, LVAD support improved force-frequency relations of isolated superfused LV trabeculae ( P =0.01) but not RV trabeculae. Conclusions — Reduction of hemodynamic load is a primary factor underlying several important features of reverse remodeling. These findings do not preclude a possible primary role of neurohormonal factors underlying other facets of reverse remodeling during LVAD support.Keywords
This publication has 14 references indexed in Scilit:
- Time course of reverse remodeling of the left ventricle during support with a left ventricular assist deviceThe Journal of Thoracic and Cardiovascular Surgery, 2001
- PKA Phosphorylation Dissociates FKBP12.6 from the Calcium Release Channel (Ryanodine Receptor)Cell, 2000
- Signaling Pathways for Cardiac Hypertrophy and FailureNew England Journal of Medicine, 1999
- Implantable Left Ventricular Assist DevicesNew England Journal of Medicine, 1998
- Mechanical Support in Dilated Cardiomyopathy: Signs of Early Left Ventricular RecoveryThe Annals of Thoracic Surgery, 1997
- Effect of the Implantable Left Ventricular Assist Device on Neuroendocrine Activation in Heart FailureCirculation, 1995
- Improved Mortality and Rehabilitation of Transplant Candidates Treated with a Long-Term Implantable Left Ventricular Assist SystemAnnals of Surgery, 1995
- Structural and left ventricular histologic changes after implantable LVAD insertionThe Annals of Thoracic Surgery, 1995
- Potential of left ventricular assist devices as outpatient therapy while awaiting transplantationThe Annals of Thoracic Surgery, 1994
- Effect of Enalapril on Survival in Patients with Reduced Left Ventricular Ejection Fractions and Congestive Heart FailureNew England Journal of Medicine, 1991